Dacula, Aisa .

HRN: 27-48-70  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/23/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/23/2025
07/30/2025
IV
500MG
Q6hours
H. PYLORI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: